Search CAH
CARDINAL HEALTH INC
NYSE · CIK 721371
Last close228.3
Daily change-1.79 (-0.78%)
10 Years gain+227.05%
Dividends TTM2.05 (+0.98%)
Dividend yield0.89%
Fundamental Analysis
CAH · STANDARD
SIC 5122 · Wholesale-Drugs, Proprietaries & Druggists' Sundries · Fiscal year end 0630
Fundamental
40.4Momentum
52.3Acceleration
52.3Confidence
82.0Annual Revenue19
Quarterly Revenue84
Annual CFO19
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth14.5 / 25
Quality15.2 / 25
Capital Efficiency0.0 / 20
Balance Sheet8.7 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 0.2709 percentage points.
Operating leverageOperating margin improved by 0.4637 percentage points.
Share count reductionDiluted share count declined 3.2653%.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Key Metrics
Revenue Growth TTM9.37%OK
Revenue CAGR 3Y7.44%OK
Gross Margin3.66%OK
Operating Margin1.11%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Y5.66%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-3.27%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 FY Jun 30, 2026 | $254.25B | $9.77B | $2.61B | $5.17B | $4.53B | 3.84% | 1.03% | 1.78% | n/a | 237M |
| 2026 FY Jun 30, 2025 | $222.58B | $8.17B | $2.28B | $2.40B | $1.85B | 3.67% | 1.02% | 0.83% | n/a | 242M |
| 2026 FY Jun 30, 2024 | $226.83B | $7.41B | $1.24B | $3.76B | $3.25B | 3.27% | 0.55% | 1.43% | n/a | 247M |
| 2025 FY Jun 30, 2023 | $204.98B | $6.87B | $752.00M | $2.84B | $2.36B | 3.35% | 0.37% | 1.15% | n/a | 262M |
| 2024 FY Jun 30, 2022 | $181.33B | $6.48B | -$607.00M | $3.18B | $2.79B | 3.58% | -0.33% | 1.54% | n/a | 279M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $239.78B | sum latest 4 fiscal quarters Revenue | OK | 0000721371-26-000006, 0000721371-25-000038 |
| Revenue Growth TTM | 9.37% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0000721371-26-000006, 0000721371-25-000038 |
| Revenue CAGR 3Y | 7.44% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0000721371-26-000038 |
| Revenue CAGR 5Y | 9.37% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0000721371-26-000038 |
| Gross Profit CAGR 3Y | 12.45% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0000721371-26-000038 |
| Operating Income Growth | 88.23% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0000721371-26-000006, 0000721371-25-000038 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 3.66% | Gross Profit / Revenue | OK | 0000721371-26-000006, 0000721371-25-000038 |
| Operating Margin | 1.11% | Operating Income / Revenue | OK | 0000721371-26-000006, 0000721371-25-000038 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0000721371-26-000006 |
| Interest Coverage | 9.58x | Operating Income / abs(Interest Expense) | OK | derived |
| Current Ratio | 0.91x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $1,011.72 | Revenue / Diluted Shares | OK | 0000721371-26-000006, 0000721371-25-000038 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |